Measurement of levels of human immunodeficiency virus type 1 reverse transcriptase (RT) and RT activity-blocking antibody in human serum by a new standardized colorimetric assay

Journal of Clinical Microbiology

Volumn 35, Issue 5, 1997, Pages 1080-1089

  Awad, Raymond J K ^a,d   Corrigan, Gary E ^b   Ekstrand, D Henric L ^a   Thorstensson, Rigmor ^c   Källander, Clas F R ^a,b   Gronowitz, J Simon ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Cavidi Tech AB   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE;

ARTICLE; COLORIMETRY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0030953480     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.5.1080-1089.1997     Document Type: Article

References (28)

1. Advani, M., D. T. Imagawa, M. H. Lee, K. Sano, F. Morales, R. T. Mitsuyasu, and R. Detels. 1989. Cross-sectional study of reverse transcriptase-inhibiting antibody as a marker of acquired immune deficiency syndrome. J. Clin. Microbiol. 27:1453-1455.
2. Burdon, R. H., P. H. van Knippenberg. 1985. In P. Tijssen (ed.), Laboratory techniques in biochemistry and molecular biology, practice and theory of enzyme immunoassays, vol. 15, p. 385-421. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
3. Chatterjee, R., C. R. Rinaldo, and P. Gupta. 1987. Immunogenicity of human immunodeficiency virus (HIV) reverse transcriptase: detection of high levels of antibodies to HIV reverse transcriptase in sera of homosexual men. J. Clin. Immunol. 7:218-224.
4. DeLeys, R., B. Vanderborght, M. Vanden Haesevelde, L. Heyndrickx, A. van Geel, C. Wauters, R. Bernaerts, E. Saman, P. Nijs, B. Willems, H. Taelman, G. van der Groen, P. Piot, T. Tersmette, J. G. Huisman, and H. van Heuverswyn. 1990. Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of West-Central African origin. J. Virol. 64:1207-1216.
5. De Vico, A. L., F. D. M. Veronese, S. L. Lee, R. C. Gallo, and M. G. Sarngadharan. 1988. High prevalence of serum antibodies to reverse transcriptase in serum of HIV-1 infected individuals. AIDS Res. Hum. Retroviruses 4:17-22.
6. DiMarzo Veronese, F., T. D. Copeland, A. L. DeVico, R. Rahman, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1986. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231:1289-1291.
7. Ekstrand, D. H. L., R. J.-K. Awad, C. F. R. Källander, and J. S. Gronowitz. 1996. A sensitive assay for the quantification of reverse transcriptase activity based on the use of carrier-bound template and non-radioactive-product detection, with special reference to human immunodeficiency-virus isolation. Biotechnol. Appl. Biochem. 23:95-105.
8. SM infection in macaques. AIDS Res. Hum. Retroviruses, in press.
9. Grimson, B., and J. Laurence. 1995. Immunodominant epitope regions of HIV-1 reverse transcriptase: correlations with HIV-1+ serum IgG inhibitory to polymerase activity and with disease progression. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 9:58-68.
10. Gronowitz, J. S., M. Neumüller, J. Lennerstrand, R. Bhikhabhai, T. Unge, H. Weltman, and C. F. R. Källander. 1991. Carrier bound templates for single tube reverse transcriptase assays and for combined purification and activity analyses with special reference to HIV. Biotechnol. Appl. Biochem. 13:127-142.
11. Gurtler, L. G., P. H. Hauser, J. Eberle, A. von Brunn, S. Knapp, L. Zekeng, J. M. Tsague, and L. Kaptue. 1994. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J. Virol. 68:1581-1585.
12. Gurtler, L. G., L. Zekeng, F. Simon, J. Eberle, J. M. Tsague, L. Kaptue, S. Brust, and S. Knapp. 1995. Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots. J. Virol. Methods 51:177-183.
13. Hu, D. J., J. D. Dondero, M. A. Rayfield, R. J. George, G. Schochetman, H. W. Jaffe, C. C. Luo, M. L. Kalish, B. G. Weniger, C. P. Pau, C. A. Schable, and J. W. Curran. 1996. The emerging diversity of HIV; the importance of global surveillance for diagnostics, research and prevention. JAMA 275:210-216.
14. Kornfeld, H., N. Riedel, G. A. Viglianti, V. Hirsch, and J. Mullins. 1987. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses. Nature (London) 326:610-613.
15. Laurence, J., A. Saunders, and J. Kulkosky. 1987. Characterization and clinical association of antibody inhibitory to reverse transcriptase activity. Science 235:1501-1504.
16. Lelie, P. N., C. L. Van der Pool, H. W. Reesink, H. G. Huisman, C. A. B. Boucher, and J. Goudsmit. 1989. Efficacy of the latest generation of antibody assays for (early) detection of HIV-1 and HIV-2 infection. Vox Sang. 56:59-61.
17. Lennerstrand, J., A.-S. Rytting, C. Örvell, J. S. Gronowitz, and C. F. R. Källander. 1996. A method for the combined immuno purification and assay of HIV-1 reverse transcriptase activity useful for crude samples. Anal. Biochem. 235:141-152.
18. Loussert-Ajaka, I., T. D. Ly, M. L. Chaix, D. Ingrand, S. Saragosti, A. M. Courouce, F. Brun-Vezinet, and F. Simon. 1494. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 343:1393-1394.
19. Loveday, C., and R. S. Tedder. 1993. Enzyme-linked immunosorbent assay for the measurement of human immunodeficiency virus type 1 reverse transcriptase antigen and antibodies. J. Virol. Methods 41:181-192.
20. Martin, D. J., N. K. Blackburn, K. F. O'Connell, E. T. Brant, and E. A. Goetsch. 1995. Evaluation of the World Health Organisation antibody testing strategy for the individual patient diagnosis of HIV infection (strategy III). S. Afr. Med. J. 85:877-889.
21. Neumüller, M., A. Karlsson, J. Lennerstrand, C. F. R. Källander, V. Holmberg, U. Långström-Persson, R. Thorstensson, E. Sandström, and J. S. Gronowitz. 1991. HIV reverse transcriptase inhibiting antibodies detected by a new technique: relation to p24 and gp41 antibodies. HIV antigenemia and clinical variables. J. Med. Virol. 34:55-63.
22. Neumüller, M., A. Karlsson, J. Lennerstrand, C. F. R. Källander, E. Sandström, V. Holmberg, and J. S. Gronowitz. 1992. HIV reverse transcriptase inhibiting antibody titre in serum: relation to disease progression and to core-antibody levels. J. Med. Virol. 36:283-291.
23. Race, E. M., K. M. Ramsey, H. L. Lucia, and M. W. Cloyd. 1991. Human immunodeficiency virus infection elicits early antibody not detected by standard tests: implications for diagnostics and viral immunology. Virology 184: 716-722.
24. Sano, K., M. H. Lee, F. Morales, P. Nishanian, J. Fahey, R. Detels, and D. T. Imagawa. 1987. Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus. J. Clin. Microbiol. 25:2415-2417.
25. Schable, C., L. Zekeng, C. P. Pau, D. Hu, L. Kaptue, L. Gurtler, T. Dondero, J. M. Tsague, G. Schochetman, H. Jaffe, and J. R. George. 1994. Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections. Lancet 344:1333-1334.
26. Urabe, T., K. Sano, T. Nakano, F. Odawara, M. H. Lee, T. Otake, S. Okubo, M. Hayami, H. Misaki, M. Baba, S. Shigeta, and M. Nakai. 1994. Differentiation between human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates by nonradioisotopic reverse transcriptase-typing assay. J. Clin. Microbiol. 32:1870-1875.
27. Vanden Haesevelde, M., J. L. Decourt, R. J. De Leys, B. Vanderborght, G. van der Groen, H. van Heuverswijn, and E. Saman. 1994. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J. Virol. 68:1586-1596.
28. World Health Organization Global Programme on AIDS. 1990. Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I/II. WHO Weekly Epidemiol. Rec. 37:281-283.